SAB Biotherapeutics, Inc. (SABS) का ट्रेलिंग P/E अनुपात है 5.4. ट्रेलिंग अर्निंग्स यील्ड है 18.35%. ग्राहम नंबर है $11.01.
इस पृष्ठ द्वारा प्रमाणित मानदंड:
समग्र SharesGrow स्कोर: 54/100 जिसमें 2/7 मानदंड उत्तीर्ण।
| Year | P/E (TTM) | PEG अनुपात | P/B अनुपात | P/S अनुपात | लाभांश उपज |
|---|---|---|---|---|---|
| 2019 | -49.1 | 0.00 | -191.37 | 128.19 | - |
| 2020 | 21.9 | -0.01 | 11.31 | 7.99 | - |
| 2021 | -19.8 | 0.11 | 8.81 | 5.58 | - |
| 2022 | -1.4 | -0.15 | 0.83 | 1.07 | - |
| 2023 | -0.9 | -0.01 | 0.66 | 16.96 | - |
| 2024 | -1.0 | 0.02 | 1.35 | 26.54 | - |
| 2025 | 5.4 | -0.05 | 0.48 | 0.00 | - |
| Year | EPS (डाइल्यूटेड) | राजस्व | शुद्ध आय | शुद्ध मार्जिन |
|---|---|---|---|---|
| 2019 | $-0.22 | $3.44M | $-8.99M | -261.1% |
| 2020 | $7.45 | $55.24M | $20.12M | 36.4% |
| 2021 | $-6.30 | $60.88M | $-17.15M | -28.2% |
| 2022 | $-4.31 | $23.9M | $-18.74M | -78.4% |
| 2023 | $-7.64 | $2.24M | $-42.19M | -1884.5% |
| 2024 | $-3.68 | $1.32M | $-34.11M | -2579.8% |
| 2025 | $-0.79 | $0.00 | $13.27M | - |
| Year | EPS (औसत) | EPS रेंज | राजस्व (औसत) | राजस्व रेंज | विश्लेषक |
|---|---|---|---|---|---|
| 2026 | $-0.73 | $-1.35 – $-0.30 | $333.33K | $333.33K – $333.33K | 3 |
| 2027 | $-0.45 | $-0.50 – $-0.43 | $83.33K | $83.33K – $83.33K | 3 |
| 2028 | $-0.47 | $-0.92 – $-0.29 | $11.87M | $11.87M – $11.87M | 6 |
| 2029 | $-0.37 | $-0.37 – $-0.37 | $83.38M | $83.38M – $83.38M | 4 |
| 2030 | $-0.03 | $-0.03 – $-0.03 | $218.48M | $218.48M – $218.48M | 2 |
